Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Reinvestment Rate of 0.39x as of December 2025, reinvesting CN¥711.93 Million (capex CN¥330.65 Million plus investments CN¥381.27 Million) from operating cash flow of CN¥1.84 Billion. Explore how much does Guangzhou Baiyunshan Pharmaceutical Hold reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 24 annual periods. Also explore total assets of Guangzhou Baiyunshan Pharmaceutical Hold for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For live market cap and broader valuation context, see Guangzhou Baiyunshan Pharmaceutical Hold stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 12.98x | CN¥3.38 Billion | CN¥260.23 Million | CN¥1.24 Billion | ▲ +649.2% |
| 2024 | 1.73x | CN¥5.96 Billion | CN¥3.44 Billion | CN¥1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | CN¥4.74 Billion | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | CN¥7.62 Billion | CN¥7.00 Billion | CN¥1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | CN¥1.30 Billion | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | CN¥1.39 Billion | CN¥585.19 Million | CN¥876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | CN¥3.63 Billion | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | CN¥909.71 Million | CN¥5.22 Billion | CN¥478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | CN¥2.57 Billion | CN¥1.83 Billion | CN¥196.77 Million | ▲ +617.1% |
| 2016 | 0.20x | CN¥477.18 Million | CN¥2.44 Billion | CN¥228.03 Million | ▼ -52.6% |
| 2015 | 0.41x | CN¥800.01 Million | CN¥1.94 Billion | CN¥515.34 Million | ▲ +105.2% |
| 2014 | 0.20x | CN¥353.65 Million | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥350.35 Million | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥52.61 Million | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥83.20 Million | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥87.56 Million | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥126.98 Million | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥122.69 Million | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥90.45 Million | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥124.36 Million | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥308.69 Million | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥173.70 Million | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥160.44 Million | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥163.53 Million | CN¥286.95 Million | CN¥163.53 Million | — |